THC

Navigating Tenet Healthcare – A Brief Overview for Investors

It hasn't been a great afternoon session for Tenet Healthcare investors, who have watched their shares sink by -4.8% to a price of $156.74. Some of you might be wondering if it's time to buy the dip. If you are considering this, make sure to check the company's fundamentals first to determine if the shares are fairly valued at today's prices.

a Decline in Expected Earnings Clouds Its Value Outlook but Priced Beyond Its Margin of Safety:

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company belongs to the Health Care sector, which has an average price to earnings (P/E) ratio of 27.61 and an average price to book (P/B) ratio of 3.69. In contrast, Tenet Healthcare has a trailing 12 month P/E ratio of 5.7 and a P/B ratio of 4.32.

Tenet Healthcare has moved 135.2% over the last year compared to 26.8% for the S&P 500 — a difference of 108.4%. Tenet Healthcare has a 52 week high of $166.89 and a 52 week low of $51.04.

Exceptional Profitability Overshadowed by Excessive Leverage:

2018 2019 2020 2021 2022 2023
Revenue (M) $18,313 $18,479 $17,640 $19,485 $19,174 $20,548
Operating Margins 9% 8% 11% 15% 12% 12%
Net Margins 3% 1% 4% 8% 5% 6%
Net Income (M) $459 $171 $768 $1,476 $1,001 $1,311
Net Interest Expense (M) $1,004 $985 $1,003 $923 $890 $901
Depreciation & Amort. (M) $802 $850 $857 $855 $841 $870
Diluted Shares (M) 104 103 106 109 111 105
Earnings Per Share $4.42 $1.65 $7.23 $13.59 $9.06 $12.51
EPS Growth n/a -62.67% 338.18% 87.97% -33.33% 38.08%
Avg. Price $27.13 $24.76 $26.57 $64.32 $75.02 $156.29
P/E Ratio 5.98 14.83 3.61 4.63 8.05 12.19
Free Cash Flow (M) $432 $563 $2,867 $910 $321 $1,623
CAPEX (M) $617 $670 $540 $658 $762 $751
EV / EBITDA 12.96 13.17 11.06 9.52 11.68 13.17
Total Debt (M) $29,288 $29,160 $31,148 $31,022 $29,868 $29,764
Net Debt / EBITDA 11.84 12.11 10.09 7.69 9.14 8.44
Current Ratio 1.2 1.21 1.47 1.38 1.34 1.51

Tenet Healthcare benefits from strong operating margins with a positive growth rate, generally positive cash flows, and slight revenue growth and increasing reinvestment in the business. The company's financial statements show a strong EPS growth trend and a decent current ratio of 1.51. However, the firm has a highly leveraged balance sheet.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS